InsiderTrades.com logo
New CBOE “special perk” helps traders target income every weekend
From DTI Trader   |   Ad
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Check out this training for the full story!

SAR Insider Trading

Insider Ownership Percentage: 6.29%
Insider Buying (Last 12 Months): £17,610.94
Insider Selling (Last 12 Months): £28,742.82

Sareum Insider Trading History Chart

This chart shows the insider buying and selling history at Sareum by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Sareum Share Price & Price History

Current Price: GBX 58.50
Price Change: ▼ Price Decrease of -4 (-6.40%)
As of 12/8/2023 01:00 AM ET

This chart shows the closing price history over time for SAR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
New CBOE “special perk” helps traders target income every weekend
From DTI Trader   |   Ad
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Check out this training for the full story!

Sareum Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/7/2023John C ReaderInsiderSell50,426GBX 57£28,742.82
9/4/2023Clive BirchInsiderBuy2,479GBX 82£2,032.78
12/28/2022Stephen ParkerInsiderBuy19,972GBX 78£15,578.16
11/23/2021Stephen ParkerInsiderBuy277,777GBX 4£11,111.08
See Full Table
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
From Autonomix   |   Ad
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for Sareum (LON:SAR)

0.06% of Sareum stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Sareum logo
Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's product pipeline includes TYK2/JAK1 kinase, which is in preclinical stage; Checkpoint Kinase 1, which has completed clinical phase II; and FLT3+Aurora kinase, which is in preclinical stage. The company was founded in 2003 and is headquartered in Cambridge, the United Kingdom.
Read More on Sareum

Today's Range

Now: GBX 58.50
Low: 55.13
High: 65

50 Day Range

MA: GBX 66.51
Low: 56
High: 82.50

52 Week Range

Now: GBX 58.50
Low: 55.10
High: 149

Volume

93,823 shs

Average Volume

81,731 shs

Market Capitalization

£41.10 million

P/E Ratio

N/A

Dividend Yield

1.10%

Beta

N/A

Who are the company insiders with the largest holdings of Sareum?

Sareum's top insider investors include:
  1. Clive Birch (Insider)
  2. John C Reader (Insider)
  3. Stephen Parker (Insider)
Learn More about top insider investors at Sareum.
New CBOE “special perk” helps traders target income every weekend
From DTI Trader   |   Ad
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Check out this training for the full story!